Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor

Author： Giorgi Mariano A Cohen Arazi Hernáán Gonzalez Claudio D Di Girolamo Guillermo

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.8, 2011-06, pp. : 1285-1295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1918-1932

Bentham Science Publishers

Access to resources Recommend Favorite

Development and Clinical use of Prasugrel and Ticagrelor

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5240-5260

Bentham Science Publishers

Access to resources Recommend Favorite

A comparison of the metabolism of clopidogrel and prasugrel

By Laizure S Casey Parker Robert B

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1417-1424

Informa Healthcare

Access to resources Recommend Favorite

Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 465-477

Bentham Science Publishers

Access to resources Recommend Favorite

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 143-150

John Wiley & Sons Inc

Access to resources Recommend Favorite